Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2016-04-30
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Self-Monitoring in Weight Loss With Technology
NCT00277771
Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity
NCT05726942
SMART 2.0: Social Mobile Approaches to Reducing weighT in Young Adults
NCT03907462
Healthetech, Inc. SMART Study
NCT00194194
The Short-Term Effect of a Technology Driven Weight Control (SMART) Program for Obese Adults
NCT00624598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smart Technology Group
The Smart Technology Group will receive a technology-based lifestyle intervention program which uses wearable technology, smartscales and smartphone applications to track and deliver feedback on caloric expenditure, physical activity, caloric intake and body weight. Participants will receive information through smartphone applications on strategies to make changes to their diet, physical activity, and weight-related behaviors along with standard 3 monthly in-person weight management visits.
Wearable technology, smartscale
Smartphone applications
Standard Weight Management Visits
Standard Weight Management Group
The Standard Weight Management Group will receive 3 monthly in-person weight management visits during which they will receive standard of care lifestyle recommendations in accordance with the 2013 American Heart Association/American College of Cardiology/The Obesity Society Guideline.
Standard Weight Management Visits
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wearable technology, smartscale
Smartphone applications
Standard Weight Management Visits
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Employed in sedentary occupations
* Own a personal smartphone with unlimited data plan or \>4 GigaByte data
* Proficient with use of smartphone applications and technology with current daily usage
* Ability to engage in moderate intensity exercise
* Weight stability for the last 2 months
* Participants must be willing to comply with all study-related procedures
Exclusion Criteria
* Cardiovascular, pulmonary, renal disease, joint disease
* Uncontrolled thyroid disease
* History of eating disorders, psychiatric disease
* History of substance abuse or dependence in the last 1 year
* Diabetes
* Shift work
* Previous weight loss surgery
* Use of weight loss drugs/diet/program in the last 6 weeks
* Inability to increase walking as a form of exercise and to engage in moderate intensity exercise
* Other conditions or medications that affect body weight/appetite/metabolism
* Serious or unstable medical or psychological conditions that would compromise the subject's safety for successful participation
* Incapable of adhering with an intensive lifestyle intervention using technology and smartphone applications
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Obesity Treatment Foundation
UNKNOWN
Temple University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cherie Vaz, MD Dipl ABOM
Role: PRINCIPAL_INVESTIGATOR
Temple University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Temple University
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23217
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.